Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "GE"

8794 News Found

Mumbai doctors perform India’s first robotic surgery to fix rare uterine defect in 23 year old
Hospitals | March 10, 2026

Mumbai doctors perform India’s first robotic surgery to fix rare uterine defect in 23 year old

Doctors recommended a robotic Strassmann Metroplasty, a reconstructive surgery that joins the two halves of the uterus into a single cavity capable of supporting pregnancy


Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India
News | March 10, 2026

Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India

Huwel’s diagnostic solutions leverage open RT-PCR system


UK pushes space-made medicines from orbit to patients with new support package
R&D | March 10, 2026

UK pushes space-made medicines from orbit to patients with new support package

The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth


EU unveils draft guidance to fast-track clinical trials during public health emergencies
Policy | March 09, 2026

EU unveils draft guidance to fast-track clinical trials during public health emergencies

The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations


Evogene narrows focus to AI-driven molecule discovery after major strategic overhaul
News | March 07, 2026

Evogene narrows focus to AI-driven molecule discovery after major strategic overhaul

Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud


Roche’s experimental obesity drug shows strong weight-loss results in mid-stage trial
News | March 07, 2026

Roche’s experimental obesity drug shows strong weight-loss results in mid-stage trial

The company announced positive topline data from the Phase II ZUPREME-1 trial


argenx reports breakthrough Phase 3 results for VYVGART in ocular myasthenia gravis
Clinical Trials | March 06, 2026

argenx reports breakthrough Phase 3 results for VYVGART in ocular myasthenia gravis

The trial met its primary endpoint, showing statistically significant improvements in Myasthenia Impairment Index (MGII) Patient-Reported Outcome (PRO) ocular scores at Week 4